GH Research PLC
GHRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001855129
No open-market purchases or sales by GH Research PLC insiders were filed in the last 90 days; 63 institutions reported holding it in 13F filings for Q2 2026, worth $1.38B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding GH Research PLC changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 35 | 34 | −1 |
| Shares | 32.6M | 31.6M | −961.0K (−3.0%) |
| Value | $325.0M | $367.2M | +$42.2M (+13.0%) |
New holders (3)
Institutions that held GH Research PLC at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| State Street Corp | 10,896 | $127.0K | 0.00% |
| Millennium Management LLC | 10,111 | $117.0K | 0.00% |
| Jefferies Group LLC | 10,000 | $116.2K | 0.00% |
Sold out (4)
Institutions that held GH Research PLC at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Boxer Capital, LLC | 1,013,399 | $10.1M |
| Penserra Capital Management LLC | 21,400 | $213.0K |
| Private Advisor Group, LLC | 10,236 | $102.0K |
| Point72 Hong Kong Ltd | 80 | $1.00K |